These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11680107)

  • 21. Risk factors for levofloxacin-nonsusceptible Streptococcus pneumoniae in community-acquired pneumococcal pneumonia: a nested case-control study.
    Kang CI; Song JH; Kim SH; Chung DR; Peck KR; So TM; Hsueh PR;
    Eur J Clin Microbiol Infect Dis; 2014 Jan; 33(1):55-9. PubMed ID: 24062235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
    Tan TQ; Mason EO; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL
    Pediatrics; 1998 Dec; 102(6):1369-75. PubMed ID: 9832571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae.
    Ewig S; Ruiz M; Torres A; Marco F; Martinez JA; Sanchez M; Mensa J
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1835-42. PubMed ID: 10351928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
    Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
    Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C; Armengol R; Mir I; Lite J; Garau J
    Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
    Jones RN; Jacobs MR; Sader HS
    Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia.
    Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
    BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk.
    Cunha BA
    Postgrad Med; 2003 Jan; 113(1):42-4, 47-8, 52-4. PubMed ID: 12545592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of pneumococcal resistance and factors influencing outcomes.
    Bishai WR
    Treat Respir Med; 2005; 4 Suppl 1():19-23. PubMed ID: 15846153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
    Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
    Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.
    Pallares R; Liñares J; Vadillo M; Cabellos C; Manresa F; Viladrich PF; Martin R; Gudiol F
    N Engl J Med; 1995 Aug; 333(8):474-80. PubMed ID: 7623879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema].
    Carlavilla AB; López-Medrano F; Chaves F; Villena V; Echave-Sustaeta J; Aguado JM
    Enferm Infecc Microbiol Clin; 2005 May; 23(5):270-3. PubMed ID: 15899177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.